GGrantIndex
Sort

17,288 grants matching multiple sclerosis

AhR and Regulatory T cells

$330,085
Susan C McKarns · University Of Missouri-Columbia · R01 · FY2014 · ES

M. LEPRAE-INDUCED CONTACT-DEPENDENT DEMYELINATION

$330,057
Anura Rambukkana · Rockefeller University · R01 · FY2006 · AI

Role of Leptin in Systemic Lupus Erythematosus

$330,043
Antonio La Cava · University Of California Los Angeles · R01 · FY2007 · AR

CYTOKINES AS PREDICTORS OF DISEASE PROGRESSION IN SCLERODERMA LUNG DISEASE

$330,043
Michael D Roth · University Of California Los Angeles · R01 · FY2007 · AR

Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy

$330,037
Chenglong Li · University Of Florida · R01 · FY2016 · NS

Linking metabolism, neural function, and aging

$330,009
Kaveh Ashrafi · University Of California, San Francisco · R01 · FY2015 · AG

Role of CD4+ regulatory T cells in T cell vaccination

$329,997
Jian Hong · Baylor College Of Medicine · R01 · FY2007 · NS

Brain Image Analysis Tools for Quantitative Longitudinal Assessment of MS

$329,993
Dzung L Pham · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2014 · NS

Mediators of Fibrosis in Scleroderma Skin and Lung

$329,967
Carol A Feghali-Bostwick · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · AR

Molecular Pharmacology of Sphingosine 1-Phosphate

$329,914
Kevin R Lynch · University Of Virginia · R01 · FY2007 · GM

Oligodendrocyte Generation--A Multifactorial Approach

$329,862
Pennsylvania State Univ Hershey Med Ctr · R01 · FY2003 · NS

Mapping the Genotype, Phenotype, and Natural History of Phelan McDermid Syndrome

$329,862
Alexander Kolevzon · Boston Children'S Hospital · U54 · FY2023 · NS

Use of Resveratrol to treat experimental multiple sclerosis

$329,840
Prakash S. Nagarkatti · University Of South Carolina At Columbia · P01 · FY2009 · AT

Molecular Pharmacology of Sphingosine 1-Phosphate

$329,812
Kevin R Lynch · University Of Virginia · R01 · FY2008 · GM

Oligodendrocyte Generation--A Multifactorial Approach

$329,804
Pennsylvania State Univ Hershey Med Ctr · R01 · FY2004 · NS

Oligodendrocyte Generation--A Multifactorial Approach

$329,744
Pennsylvania State Univ Hershey Med Ctr · R01 · FY2005 · NS

Molecular Pharmacology of Sphingosine 1-Phosphate

$329,707
Kevin R Lynch · University Of Virginia · R01 · FY2009 · GM

The Gut Microbiome in Neurodegenerative Disease

$329,670
Sarkis K Mazmanian · California Institute Of Technology · R01 · FY2014 · NS

Role of MMP-9 in selective motor neuron degeneration in ALS

$329,585
Serge E Przedborski · Columbia University Health Sciences · R01 · FY2015 · NS

SELECTIVE ELECTRICAL STIMULATION OF THALAMIC NEURONS

$329,563
Case Western Reserve University · R01 · FY2003 · NS

K-Channels in Lymphocyte Function and Autoimmunity

$329,541
George Kanianthara Chandy · University Of California-Irvine · R01 · FY2008 · NS

Human and Machine Learning for Customized Control of Assistive Robots

$329,494
Brenna Argall · Rehabilitation Institute Of Chicago D/B/A Shirley Ryan Abilitylab · R01 · FY2019 · EB

Mechanisms of Oligodendrocyte Fate Specification in the Developing Neocortex

$329,473
Santos Joe Franco · University Of Colorado Denver · R01 · FY2023 · NS

Mechanisms of Oligodendrocyte Fate Specification in the Developing Neocortex

$329,473
Santos Joe Franco · University Of Colorado Denver · R01 · FY2022 · NS

Mechanisms of Oligodendrocyte Fate Specification in the Developing Neocortex

$329,473
Santos Joe Franco · University Of Colorado Denver · R01 · FY2020 · NS